Company

Vima Therapeutics

Biotechnology Research The Root Brain Causes. Vima Therapeutics Is Testing an Experimental Oral Medicine Going After Muscarinic Cholinergic Receptors. 13 employees

Employees: 13
Contacts: 4
Emails: 4
Phones: 3

www.vimatx.com LinkedIn Crunchbase

Vima Therapeutics Overview

Headquarters: The Root Brain Causes. Vima Therapeutics Is Testing an Experimental Oral Medicine Going After Muscarinic Cholinergic Receptors.
Website: www.vimatx.com
Industry: Biotechnology Research
Employees: 13
Funding: 60.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in movement disorders and a shared commitment to deliver a meaningful oral therapy for patients.

About Vima Therapeutics

Vima Therapeutics is a clinical-stage biotechnology company pioneering a new era in the treatment of dystonia and related movement disorders. We are advancing VIM0423, a potential first-in-class oral therapy for dystonia, with the goal of helping individuals regain control of their movements by targeting the underlying cause of the disease. Vima brings together a team of physicians, scientists, and drug developers with deep expertise in movement disorders and a shared commitment to deliver a meaningful oral therapy for patients.

Vima Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Vima Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Bernard Ravina	Chief Executive Officer, Vima Therapeutics	Cambridge, Massachusetts, United States	Email Phone
Jessica Fees		Suffolk County, Massachusetts, United States	Email
Judith Dunn		Cambridge, Massachusetts, United States	Email Phone
Natalie Chauvin	VP, Finance and HR at Vima Therapeutics	Boston, Massachusetts, United States	Email Phone